Boeing (BA.N) CEO: We expect to generate approximately $2 billion in free cash flow in 2026.

Key News 1. National Bureau of Statistics: From January to September, the total profits of industrial enterprises above designated size nationwide reached 6,033.74 billion yuan, a year-on-year increase of 15.5%. 2. Henan: During the 15th Five-Year Plan period, the focus will be on diamond applications such as heat dissipation, and the implementation of major provincial-level projects for superhard materials. 3. 13 companies in the Science and Technology Innovation Board's Top 50 companies are implementing share repurchase plans, with the upper limit expected to exceed 5 billion yuan. Individual Stock News 1. Data on main force capital flows shows that Snowman Group saw the largest net inflow of main force capital at 617 million yuan, followed by Dayang Electric, Zhongji Xuchuang, Guangdong Media, and Industrial Bank; Cambricon saw the largest net outflow of main force capital at 681 million yuan, followed by Xiechuang Data, Xingyun Technology, AMEC, and Xin Yisheng. 2. Orbbec: Its data acquisition business is in a critical period of customer introduction and ecosystem construction. 3. Jiangte Electric: The pilot project for the embodied intelligent rehabilitation cooperation project has been launched. 4. Xinji Energy: Long-term electricity price negotiations for 2027 are progressing as planned. 5. Penghui Energy: Has cooperation with leading domestic customers and has delivered small-batch samples for humanoid robot batteries. 6. Xiaoming Shares: Will launch chicken embryo egg raw material products in 2026. 7. Guoci Materials: High-end MLCC products have passed verification by some customers and are expected to be supplied in batches in the fourth quarter. 8. Xiamen Tungsten: Will continue to carry out mergers and acquisitions to strengthen, supplement, and extend the industrial chain. 9. When will the cooperation function with Tencent WorkBuddy be launched? Ugreen Technology's latest response. 10. Qianhong Pharmaceutical: The QHRD106 injection project is in the final stage of Phase IIb clinical trials.

A senior Ukrainian official said the ceasefire in Oreshki will last until November 1.